Streptococcus salivarius Role as a Probiotic in Children’s Health and Disease Prophylaxis—A Systematic Review
Open Access
Abstract
Background: This systematic review aimed to synthesize the existing evidence on the use of Streptococcus salivarius (S. salivarius) probiotics as prophylactic or therapeutic tools for pediatric oral, dental, and respiratory diseases. Methods: A comprehensive search was carried out across multiple databases using the following terms: S. salivarius, probiotic, children, pediatric. Results: The systematic literature search identified 613 publications, which were meticulously screened, and, ultimately, 15 suitable citations were included in this systematic review. Three strains of S. salivarius (M18, K-12, 24SMB) were used, and they all demonstrated positive benefits in pediatric pathology. Conclusions: Administration of S. salivarius has benefits, is effective, and is convenient (cost-effective) in pediatric prophylaxis. Oral administration as a chewable tablet or powder of S. salivarius M18 for 3 months is able to reduce the incidence of black stains, plaque, and tooth decay in children. S. salivarius K-12 treatment decreased the occurrence of pharyngeal, recurrent, and streptococcal disease, and the benefits also extend to a reduction of nonstreptococcal diseases, including tracheitis, viral pharyngitis, rhinitis, flu, laryngitis, acute otitis media, and enteritis. Administration of S. salivarius 24SMB as an intranasal spray was able to reduce the risk of acute otitis media in children prone to this condition.Keywords
This publication has 40 references indexed in Scilit:
- Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A reviewWorld Journal of Otorhinolaryngology - Head and Neck Surgery, 2021
- Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients With Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Effect of Oral Probiotic Streptococcus salivarius K12 on Group A Streptococcus Pharyngitis: A Pragmatic Trial in SchoolsThe Pediatric Infectious Disease Journal, 2018
- Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone childrenEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015
- Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015
- Lactobacillus rhamnosus GG in the middle ear after randomized, double-blind, placebo-controlled oral administrationInternational Journal of Pediatric Otorhinolaryngology, 2014
- Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trialJournal of Medical Microbiology, 2013
- Challenges in reducing the burden of otitis media disease: An ENT perspective on improving management and prospects for preventionInternational Journal of Pediatric Otorhinolaryngology, 2010
- Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12European Journal of Clinical Microbiology & Infectious Diseases, 2008
- Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real‐time quantitative polymerase chain reactionOral Microbiology and Immunology, 2007